3,3',4,4'位に4個の重水素原子を含む。GC-またはLC-質量分析法による11β-PGF2αの定量用内部標準物質として使用される。1 11β-PGF2αの通常のヒト尿中排泄量は約54ng/mmolクレアチニンであり、喘息患者のアレルゲン誘発性気管支収縮時には約3倍に増加する2。11β-PGF2αは、ヒト気管支平滑筋収縮および脂肪分化の抑制においてPGF2αと同等である3,4。11β-PGF2αは、ADPまたはトロンビン誘発ヒト血小板凝集を0.14~2.8μMの濃度で阻害する5。
11β-Prostaglandin F2α-d4 (CAS 1240398-18-8) 参考文献
1 Liston, T.E., Roberts, L.J. Transformation of prostaglandin D2 to 9α,11β-(15S)-trihydroxy-prosta-(5Z,13E)-dien-1-oic acid (9α,11β-prostaglandin F2): A unique biologically active prostaglandin produced enzymatically in vivo in humans. Proc Natl Acad Sci USA 82 6030-6034 (1985). 2 O'Sullivan, S., Dahlén, B., Dahlén, S., et al. Increased urinary excretion of the prostaglandin D2 metabolite 9α,11β-prostaglandin F2 after aspirin challenge supports mast cell activation in aspirin-induced airway obstruction. J Allergy Clin Immunol 98 421-432 (1996). 3 Coleman, R.A., Sheldrick, R.L.G. Prostanoid-induced contraction of human bronchial smooth muscle is mediated by TP-receptors. Br J Pharmacol 96 688-692 (1989). 4 Lepak, N.M., Serrero, G. Inhibition of adipose differentiation by 9α, 11β-prostaglandins F2α Prostaglandins 46, 511-517 (1993). 5 Pugliese, G., Spokas, E.G., Marcinkiewicz, E., et al. Hepatic transformation of prostaglandin D2 to a new prostanoid, 9α,11β-prostaglandin F2, that inhibits platelet aggregation and constricts blood vessels. J Biol Chem 260 14621-14625 (1985)